Functional Characterization of Colon-Cancer-Associated Variants in <i>ADAM17</i> Affecting the Catalytic Domain

Although extensively investigated, cancer is still one of the most devastating and lethal diseases in the modern world. Among different types, colorectal cancer (CRC) is most prevalent and mortal, making it an important subject of research. The metalloprotease ADAM17 has been implicated in the devel...

Full description

Bibliographic Details
Main Authors: Jan Philipp Dobert, Anne-Sophie Cabron, Philipp Arnold, Egor Pavlenko, Stefan Rose-John, Friederike Zunke
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/8/11/463
_version_ 1827703100833529856
author Jan Philipp Dobert
Anne-Sophie Cabron
Philipp Arnold
Egor Pavlenko
Stefan Rose-John
Friederike Zunke
author_facet Jan Philipp Dobert
Anne-Sophie Cabron
Philipp Arnold
Egor Pavlenko
Stefan Rose-John
Friederike Zunke
author_sort Jan Philipp Dobert
collection DOAJ
description Although extensively investigated, cancer is still one of the most devastating and lethal diseases in the modern world. Among different types, colorectal cancer (CRC) is most prevalent and mortal, making it an important subject of research. The metalloprotease ADAM17 has been implicated in the development of CRC due to its involvement in signaling pathways related to inflammation and cell proliferation. ADAM17 is capable of releasing membrane-bound proteins from the cell surface in a process called <i>shedding.</i> A deficiency of ADAM17 activity has been previously shown to have protective effects against CRC in mice, while an upregulation of ADAM17 activity is suspected to facilitate tumor development. In this study, we characterize ADAM17 variants found in tissue samples of cancer patients in overexpression studies. We here focus on point mutations identified within the catalytic domain of ADAM17 and could show a functional dysregulation of the CRC-associated variants. Since the catalytic domain of ADAM17 is the only region structurally determined by crystallography, we study the effect of each point mutation not only to learn more about the role of ADAM17 in cancer, but also to investigate the structure–function relationships of the metalloprotease.
first_indexed 2024-03-10T15:11:39Z
format Article
id doaj.art-20a2e71ba50d48f78831e1d9b5fa94ac
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-10T15:11:39Z
publishDate 2020-10-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-20a2e71ba50d48f78831e1d9b5fa94ac2023-11-20T19:15:51ZengMDPI AGBiomedicines2227-90592020-10-0181146310.3390/biomedicines8110463Functional Characterization of Colon-Cancer-Associated Variants in <i>ADAM17</i> Affecting the Catalytic DomainJan Philipp Dobert0Anne-Sophie Cabron1Philipp Arnold2Egor Pavlenko3Stefan Rose-John4Friederike Zunke5Institute of Biochemistry Christian-Albrechts-Universität zu Kiel, 24118 Kiel, GermanyInstitute of Biochemistry Christian-Albrechts-Universität zu Kiel, 24118 Kiel, GermanyInstitute of Anatomy, Christian-Albrechts-Universität zu Kiel, 24118 Kiel, GermanyInstitute of Biochemistry Christian-Albrechts-Universität zu Kiel, 24118 Kiel, GermanyInstitute of Biochemistry Christian-Albrechts-Universität zu Kiel, 24118 Kiel, GermanyInstitute of Biochemistry Christian-Albrechts-Universität zu Kiel, 24118 Kiel, GermanyAlthough extensively investigated, cancer is still one of the most devastating and lethal diseases in the modern world. Among different types, colorectal cancer (CRC) is most prevalent and mortal, making it an important subject of research. The metalloprotease ADAM17 has been implicated in the development of CRC due to its involvement in signaling pathways related to inflammation and cell proliferation. ADAM17 is capable of releasing membrane-bound proteins from the cell surface in a process called <i>shedding.</i> A deficiency of ADAM17 activity has been previously shown to have protective effects against CRC in mice, while an upregulation of ADAM17 activity is suspected to facilitate tumor development. In this study, we characterize ADAM17 variants found in tissue samples of cancer patients in overexpression studies. We here focus on point mutations identified within the catalytic domain of ADAM17 and could show a functional dysregulation of the CRC-associated variants. Since the catalytic domain of ADAM17 is the only region structurally determined by crystallography, we study the effect of each point mutation not only to learn more about the role of ADAM17 in cancer, but also to investigate the structure–function relationships of the metalloprotease.https://www.mdpi.com/2227-9059/8/11/463ADAM17colorectal cancer (CRC)TNFαIL-6RAREGshedding
spellingShingle Jan Philipp Dobert
Anne-Sophie Cabron
Philipp Arnold
Egor Pavlenko
Stefan Rose-John
Friederike Zunke
Functional Characterization of Colon-Cancer-Associated Variants in <i>ADAM17</i> Affecting the Catalytic Domain
Biomedicines
ADAM17
colorectal cancer (CRC)
TNFα
IL-6R
AREG
shedding
title Functional Characterization of Colon-Cancer-Associated Variants in <i>ADAM17</i> Affecting the Catalytic Domain
title_full Functional Characterization of Colon-Cancer-Associated Variants in <i>ADAM17</i> Affecting the Catalytic Domain
title_fullStr Functional Characterization of Colon-Cancer-Associated Variants in <i>ADAM17</i> Affecting the Catalytic Domain
title_full_unstemmed Functional Characterization of Colon-Cancer-Associated Variants in <i>ADAM17</i> Affecting the Catalytic Domain
title_short Functional Characterization of Colon-Cancer-Associated Variants in <i>ADAM17</i> Affecting the Catalytic Domain
title_sort functional characterization of colon cancer associated variants in i adam17 i affecting the catalytic domain
topic ADAM17
colorectal cancer (CRC)
TNFα
IL-6R
AREG
shedding
url https://www.mdpi.com/2227-9059/8/11/463
work_keys_str_mv AT janphilippdobert functionalcharacterizationofcoloncancerassociatedvariantsiniadam17iaffectingthecatalyticdomain
AT annesophiecabron functionalcharacterizationofcoloncancerassociatedvariantsiniadam17iaffectingthecatalyticdomain
AT philipparnold functionalcharacterizationofcoloncancerassociatedvariantsiniadam17iaffectingthecatalyticdomain
AT egorpavlenko functionalcharacterizationofcoloncancerassociatedvariantsiniadam17iaffectingthecatalyticdomain
AT stefanrosejohn functionalcharacterizationofcoloncancerassociatedvariantsiniadam17iaffectingthecatalyticdomain
AT friederikezunke functionalcharacterizationofcoloncancerassociatedvariantsiniadam17iaffectingthecatalyticdomain